Actively Recruiting
The Extended Salford Lung Study ("Ex-SLS") Data Access Project
Led by GlaxoSmithKline · Updated on 2025-12-18
3500
Participants Needed
1
Research Sites
524 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Salford Lung Study (SLS) subjects represent a group of COPD and asthma patients whose disease is extremely well-characterised over a short time period. Subjects in the SLS originally consented for information relevant to the study to be shared with the sponsor (GSK). These data were limited to three years prior to randomisation and the twelve-month interventional treatment period. Broadened access to patients' data would allow SLS subjects' entire disease journey to be researched, presenting a rare opportunity to improve scientific and clinical understanding of COPD/asthma disease risk, treatment and progression. This proposal seeks to collect additional subject-level data from SLS patients via their electronic medical records (encompassing past and future data for up to 10 years from the date of consent) and via a one-off patient questionnaire administered at the time of consent.
CONDITIONS
Official Title
The Extended Salford Lung Study ("Ex-SLS") Data Access Project
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects who were randomized to treatment in the original SLS studies
- Subjects who are able to, and choose to, provide written consent for the additional information to be collected.
You will not qualify if you...
- Subjects who were lost to follow-up, moved away, withdrew consent, or died during or after the original SLS studies
- Subjects considered too ill to participate or without the mental capacity to provide informed consent, as determined by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
GSK Investigational Site
Manchester, United Kingdom, M274AF
Actively Recruiting
Research Team
U
US GSK Clinical Trials Call Center
CONTACT
E
EU GSK Clinical Trials Call Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here